Platform
Features
Pricing
0 followers
Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.
Industries
Headquarters
Employees
Links
Randall B Riggs
6 members
5 members
Agilent Technologies
63 followers
Vertex Pharmaceuticals
55 followers
Takeda Oncology
12 followers
Accolade
24 followers
Bullard
1 follower
Allergan Aesthetics
5 followers
Ovation Healthcare
Lonza
30 followers
Helaina
Integrated DNA Technologies
2 followers
Kenvue
21 followers
Explore companies